Articles by William Looney - Pharmaceutical Executive

ADVERTISEMENT

Articles by William Looney

Heading for the Horizon

Jun 1, 2011

Now that government payers are turning to pharma to bridge budgetary shortfalls it's best to think long-term

Keeping Your Place on the Nifty 50

May 1, 2011

What do the Pharm Exec 50 numbers tell us? The dominant theme seems to be one of gradual restructuring toward a post-patent-cliff era.

The Big Business of Boosting Performance

Apr 1, 2011

Dutch-based DSM N.V. is seeking innovatinve ways to partner through bolstering manufacturing

Platforms for Peerless Performance

Apr 1, 2011

A true performance culture has to focus on the mundane as much as the sublime

How US Health Reform Is Hitting Canada

Apr 1, 2011

Canada's Russell Williams, of Rx&D, talks about the impact of US health reform on his role as chief spokesman for the country's R&D industry

John Castellani: Industry's Level Bet on a Dizzying Future

Will reinforced evidence and messaging continue to deliver results in a changing healthcare marketplace? Can PhRMA's own business model synch with industry's? Pharm Exec takes a closer look at PhRMA's new leadership
Mar 1, 2011

Can PhRMA's own business model synch with industry's Pharm Exec takes a closer look at PhRMA's new leadership.

Making Sense of Market Chaos

Mar 1, 2011

Pharma can be an insular industry, with limited capacity to gaze beyond its own narrow frame of vision

The Night Stalkers: Keeping CEOs Awake in 2011

Feb 4, 2011

"Tops in Fraud" is a ruinous moniker for pharma—a business so dependent on basic issues of trust, integrity, quality and safety

Tracking the US Market: A Statistical Self-Portrait

Feb 1, 2011

What are some of the essential characteristics of the US market? Statistics drawn from the 2011 Statistical Abstract of the US shed some light

ADVERTISEMENT

Click here